The biotechnology company posted revenue of $601.3 million in the period, also topping Street forecasts. Seven analysts surveyed by Zacks expected ...
News
- Seattle Genetics: 4Q Earnings Snapshot
- Otonomy: 4Q Earnings Snapshot
The biotechnology company posted revenue of $53,000 in the period, missing Street forecasts. Three analysts surveyed by Zacks expected $416,000.
- Ultragenyx: 4Q Earnings Snapshot
The biotechnology company posted revenue of $91.5 million in the period, surpassing Street forecasts. Seven analysts surveyed by Zacks expected ...
- Sununu budget includes tax cuts, higher education merger
Another $10 million would expand funding for student loan repayment for those pursuing careers in health care, biotechnology and other fields.
- Public option in Biden plan could change the face of US health care
Also limit price increases for all brand, biotech and generic drugs to the rate of inflation. -. Allow consumers to buy prescription drugs from other countries ...